Health
Drug enhances bone marrow transplant outcomes for leukaemia patients – Health Europa
Experts have identified a drug that reduces the risk of leukaemia recurring when administered in combination with a bone marrow…
A team of researchers from the University of Michigan Health Rogel Cancer Center have ascertained that a treatment known as interferon can lower the risk of leukaemia recurrence in high-risk patients by 20% when given alongside a bone marrow transplant.
…
Continue Reading
-
Noosa News24 hours agoTayla Harris stars as Melbourne defeats Essendon by 14 points
-
General24 hours agoa pivotal moment in Liberal power struggle
-
General11 hours agoAustralia welcomes Gaza peace progress, hostage release
-
Business13 hours agoBell Potter names the best ASX shares to buy in October